Peripal develops and commercializes a patient aid for the chronic patient population in dialysis, supporting a critical therapy step: the manual connection of tubings.

The Peripal System will

  • Simplify therapy process: The therapy process can be streamlined.
  • Increase in access to therapy: The device can broaden the patient base eligible for peritoneal dialysis.
  • Shorten patient training times: Because several previously manual therapy steps are concentrated within the device, training times for patients should be shorter.
  • Enable assisted home therapy: The Peripal system is an important element because it makes assisted peritoneal dialysis financially more viable.

There is an unmet need for such a device. Preliminary market research indicates that doctors would prescribe such a patient aid to 15%-30% of their patients.

The system is IP protected (patent pending).